3. Problems with use of AMA
• Toxicity: Local and systemic
• Hypersensitivity reactions
• Drug resistance
4. Unresponsiveness of a microbe to an AMA
• It refers to tolerance of microorganism to
inhibitory actions of AMA
• Natural resistance
• Acquired resistance
It is the development of resistance by an
organism due to the use of AMA over a period
of time
• Can happen with any microbe
• Depends upon microbes and drugs
5. Prevention of drug resistance
• Using AMA for appropriate period
• Prefer selective AMA (narrow)
• In prolonged therapy use combination of
AMA, Eg. Tuberculosis
• Intensive therapy for the organism known to
develop resistance, Eg: Tuberculosis
6. Super infection (Supra infection)
• Appearance of new infection as a result of
antimicrobial therapy
Commonly seen in
• Compromised host defence
– AIDS, diabetes, corticosteroid therapy,
anticancer drug therapy
• Use of broad spectrum antibiotics
8. Combination of AMA
• To achieve synergism
• To ↓ adverse effects
• To prevent resistance development
• To broaden spectrum of AMA
9. Chemoprophylaxis
• This refers to the use of AMA for
preventing the setting in of an infection or
suppressing contacted infection before it
becomes clinically manifest
– Rheumatic fever – Benzathine penicillin
– Tuberculosis – Isoniazid
– M. meningitis – Rifampicin
– Malaria - Chloroquine
10. Cotrimoxazole
• A fixed dose combination of
sulfamethaxazole and trimethaprim
• Causes sequential block of folate
metabolism
• Individually bacteriostatic
• Together – Bacteriocidal
• Synergestic effect